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ABSTRACT 
Mesenchymal stem cells (MSCs) are multipotent stem cells with ability to differentiate into cells of the 
connective tissue lineage, such as adipocytes, osteoblasts and chondrocytes, both in vitro and in vivo. The 
main objective of the present thesis was to study different aspects of the osteogenic potential of MSCs. By 
examining markers of differentiation, exploring approaches for enhanced osteogenesis through the use of 
small molecule substances, and studying the interactions between MSCs and inflammatory cells/signals, 
we aimed to gain new insights into factors and mechanisms involved in regulation of the osteogenic 
differentiation process.  
Through both a virtual ligand-based screening method combined with several in vitro screening steps, 
and a chemical inhibition of the PPAR-γ transcription factor, it was demonstrated that osteogenic 
differentiation of MSCs can be modulated by the use of a small molecule substance. Furthermore, a link 
between PPAR-γ, leptin and osteogenic differentiation was revealed. 
The surface markers CD10 and CD92, and intracellular protein CRYaB were demonstrated as suitable 
markers for monitoring and evaluating the differentiation of MSCs. CD10 and CD92 were shown to be 
markers of both osteogenic and adipogenic differentiation, whereas CRYaB was revealed as a marker 
specific for the osteogenic lineage. 
Activated human monocytes communicate pro-osteogenic signals to MSCs, independent of direct cell-
cell contact. Furthermore, membrane vesicles isolated from gram-positive bacterial strains Staphylococcus 
aureus and Staphylococcus epidermidis also promote osteogenic differentiation of MSCs as well as modulate 
their secretion of signals related to inflammation and immune-modulation. 
In conclusion, the present thesis presents new findings regarding the phenotype of MSCs characteristic 
for osteogenic differentiation. Furthermore, through the results presented here insight is gained into 
several key factors, both of synthetic and biological origin, important in this process. This knowledge is 
valuable for future strategies with the aim of enhancing osteogenic regeneration.  
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